Wakamoto Pharmaceutical Co (TSE:4512) Total Tax Payable: 円261 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4512 Wakamoto Pharmaceutical Co Ltd TSE:4512
63 GF Score
Price 円264.00
GF Value 円309.20
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Wakamoto Pharmaceutical Co Total Tax Payable?

Wakamoto Pharmaceutical Co TSE:4512 +0.38% 63 Total Tax Payable is 円261 Mil as of Mar. 2026. GuruFocus rates TSE:4512 with a GF Score™ of 63/100 and a GF Value™ of 円309.20 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Wakamoto Pharmaceutical Co's Total Tax Payable for the quarter that ended in Mar. 2026 was 円261 Mil.

Wakamoto Pharmaceutical Co's quarterly Total Tax Payable increased from Sep. 2025 (円47 Mil) to Dec. 2025 (円188 Mil) and increased from Dec. 2025 (円188 Mil) to Mar. 2026 (円261 Mil).

Wakamoto Pharmaceutical Co's annual Total Tax Payable increased from Mar. 2024 (円28 Mil) to Mar. 2025 (円45 Mil) and increased from Mar. 2025 (円45 Mil) to Mar. 2026 (円261 Mil).

Wakamoto Pharmaceutical Co Total Tax Payable Related Terms

Wakamoto Pharmaceutical Co Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Wakamoto Pharmaceutical Co's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wakamoto Pharmaceutical Co Total Tax Payable Chart

Wakamoto Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Tax Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71.28 165.64 27.82 45.00 261.37

Wakamoto Pharmaceutical Co Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 45.00 30.00 47.27 188.17 261.37
TSE:4512
63GF Score
Wakamoto Pharmaceutical Co Ltd TSE:4512
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wakamoto Pharmaceutical Co Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of 円261 Mil mean?
Wakamoto Pharmaceutical Co (TSE:4512) has a Total Tax Payable of 円261 Mil as of Mar. 2026. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Wakamoto Pharmaceutical Co and its competitors.
Is Wakamoto Pharmaceutical Co's Total Tax Payable too high?
Wakamoto Pharmaceutical Co's current Total Tax Payable is 円261 Mil. Overall, Wakamoto Pharmaceutical Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Wakamoto Pharmaceutical Co's Total Tax Payable compare to ZTS?
Wakamoto Pharmaceutical Co's Total Tax Payable of 円261 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Drug Manufacturers company?
A good Total Tax Payable depends on the Drug Manufacturers industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Wakamoto Pharmaceutical Co and its competitors. Wakamoto Pharmaceutical Co's current Total Tax Payable is 円261 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wakamoto Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Wakamoto Pharmaceutical Co (TSE:4512) is currently considered Modestly Undervalued. The stock's GF Value™ is 円309.20, compared to a current price of 円264.00 — trading 14.6% below its estimated fair value. The current Total Tax Payable is 円261 Mil. Wakamoto Pharmaceutical Co's overall GF Score™ is 63/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Wakamoto Pharmaceutical Co (TSE:4512), the current Total Tax Payable is 円261 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wakamoto Pharmaceutical Co (TSE:4512) Overvalued in 2026?

Based on GuruFocus' analysis, Wakamoto Pharmaceutical Co stock appears to be undervalued. The current stock price of 円264.00 is trading 14.6% below its estimated GF Value™ of 円309.20. GuruFocus considers Wakamoto Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for TSE:4512:

  • Total Tax Payable: 円261 Mil
  • GF Value™: 円309.20 vs. price of 円264.00 (14.6% below fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the TSE:4512 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Wakamoto Pharmaceutical Co Business Description

Address 2-2-2, Nihonbashi Honcho, Chuo-ku, Tokyo, JPN, 103-8330
Wakamoto Pharmaceutical Co Ltd is the pharmaceutical company based in Japan. It is engaged in the research and development, production and sale of ethical drugs and non-prescription drugs. The company specializes in therapeutic and diagnostic agents for ophthalmic disorders. It offers Strong Wakamoto, a gastrointestinal drug for digestion, the intestinal function controlling, and nutritional supply.
63GF Score

Get the complete analysis for TSE:4512

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円264.00
Price
円309.20
GF Value